ACIP Presentation Slides: October 2016 Meeting

October 19, 2016

Welcome

• Welcome and Introductions [13 pages]
  Dr. A Cohn
  Dr. N Bennett

Hepatitis Vaccines

• Introduction [7 pages]
  Dr. J Romero
• Revised ACIP Hepatitis B (HepB) Vaccine Recommendations [45 pages]
  Dr. S Schillie
• VFC Resolution Update [12 pages]
  Dr. J Santoli

Pertussis

• Introduction [11 pages]
  Dr. L Riley
• Guidance on the use of Tdap during pregnancy [34 pages]
  Dr. J Liang
• Updated ACIP statement for pertussis, tetanus and diphtheria vaccines [16 pages]
  Dr. J Liang

Human Papillomavirus (HPV) Vaccine

• Introduction [8 pages]
  Dr. A Kempe
• 2-Dose HPV Vaccination Schedules: Review of Evidence [39 pages]
  Dr. L Markowitz
• Proposed recommendations for 2-dose HPV vaccination [22 pages]
  Dr. E Meites
• VFC Resolution [8 pages]
  Dr. J Santoli

Top of Page

Meningococcal Vaccines

• Introduction [7 pages]
  Dr. D Stephens
• Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak [42 pages]
  Dr. H Soeters
• Immunogenicity Studies of MenB Vaccines in Adults [24 pages]
  Dr. D Granoff
• Considerations For Use of 2- and 3-Dose Schedules of MenB-FHbp (Trumenba®) [19 pages]
  Ms. J MacNeil

Herpes Zoster Vaccines

• Introduction [6 pages]
  Dr. E Belongia
• Update on Herpes Zoster [31 pages]
  Dr. K Dooling
• Investigational Herpes Zoster Adjuvanted Subunit (HZ/su) Vaccine: Efficacy in People 70 Years and OlderDr. T Heineman [27 pages]
  Dr. R Colindres

Yellow Fever Vaccine

• Update on Yellow Fever Vaccine Supply in the U.S. [12 pages]
  Dr. M Gershman

Update: Zika Virus

• Zika virus disease epidemiology in the Americas, 2015–2016 [19 pages]
  Ms. S Martin

Child/adolescent Immunization Schedule

• Introduction [5 pages]
  Dr. J Romero
• Recommended Child/adolescent immunization schedule [21 pages]
  Dr. C Robinson

Adult Immunization Schedule

• Introduction [5 pages]
  Dr. L Riley
• Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2017 [29 pages]
  Dr. D Kim

Pneumococcal Vaccine

• Introduction [8 pages]
  Dr. A Kempe
• Changes in Invasive Pneumococcal Disease (IPD) Following 5 Years of 13-valent Pneumococcal Conjugate Vaccine Use in the U.S. [13 pages]
  Ms. T Pilishvili
• Impact of PCV13 use among adults with and without indications for PCV13 use [20 pages]
  Dr. S Ahmed
• Outline of research agenda to inform potential policy reconsideration in 2018 for PCV13 use among adults [19 pages]
  Ms. T Pilishvili

Influenza

• Introduction [4 pages]
  Dr. C Walter
• Influenza Epidemiology and Surveillance Update [19 pages]
  Ms. L Brammer
• Quadrivalent Afluria® Influenza Vaccine Adult (18 years of age and older) Study [21 pages]
  Dr. G Sylvester

Respiratory Syncytial Virus (RSV) Vaccine

• Introduction [7 pages]
  Dr. R Atmar
• Epidemiology and Impact of RSV in Older Adults
  Dr. A Falsey

ACIP Evidence-Based Recommendations

• Workgroup Update [11 pages]
  Dr. W Carr

Vaccine Supply

• Update [6 pages]
  Dr. J Santoli

 Top of Page